These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8400277)

  • 1. Role of interleukin-6 in paraneoplastic thrombocytosis.
    Blay JY; Favrot M; Rossi JF; Wijdenes J
    Blood; 1993 Oct; 82(7):2261-2. PubMed ID: 8400277
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival.
    Walther MM; Johnson B; Culley D; Shah R; Weber J; Venzon D; Yang JC; Linehan WM; Rosenberg SA
    J Urol; 1998 Mar; 159(3):718-22. PubMed ID: 9474133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma.
    Blay JY; Rossi JF; Wijdenes J; Menetrier-Caux C; Schemann S; Négrier S; Philip T; Favrot M
    Int J Cancer; 1997 Jul; 72(3):424-30. PubMed ID: 9247285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic thrombocytosis in ovarian cancer.
    Stone RL; Nick AM; McNeish IA; Balkwill F; Han HD; Bottsford-Miller J; Rupairmoole R; Armaiz-Pena GN; Pecot CV; Coward J; Deavers MT; Vasquez HG; Urbauer D; Landen CN; Hu W; Gershenson H; Matsuo K; Shahzad MM; King ER; Tekedereli I; Ozpolat B; Ahn EH; Bond VK; Wang R; Drew AF; Gushiken F; Lamkin D; Collins K; DeGeest K; Lutgendorf SK; Chiu W; Lopez-Berestein G; Afshar-Kharghan V; Sood AK
    N Engl J Med; 2012 Feb; 366(7):610-8. PubMed ID: 22335738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
    O'Byrne KJ; Dobbs N; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
    [No Abstract]   [Full Text] [Related]  

  • 6. Paraneoplastic thrombocytosis in gastrointestinal cancer.
    Baranyai Z; Jósa V; Tóth A; Szilasi Z; Tihanyi B; Zaránd A; Harsanyi L; Szállási Z
    Platelets; 2016 Jun; 27(4):269-75. PubMed ID: 27136385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic thrombocytosis is associated with increased mortality and increased rate of lymph node metastasis in oesophageal adenocarcinoma.
    Agoston AT; Srivastava A; Zheng Y; Bueno R; Odze RD; Szallasi Z
    Pathology; 2017 Aug; 49(5):471-475. PubMed ID: 28668174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High platelet count multiplies risk following renal cell carcinoma treatment.
    Urol Nurs; 2001 Jun; 21(3):224-5. PubMed ID: 11998657
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma.
    Altundag O; Altundag K; Gunduz E
    J Clin Oncol; 2005 Feb; 23(5):1044; author reply 1044-5. PubMed ID: 15701926
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
    Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
    Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
    Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Solitary hypertransaminasemia associated with a hypernephroma: Stauffer's syndrome].
    Núñez Sánchez JC; Miro Silvestre F
    An Med Interna; 1991 May; 8(5):259-60. PubMed ID: 1912200
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator.
    Stadler WM; Richards JM; Vogelzang NJ
    J Natl Cancer Inst; 1992 Dec; 84(23):1835-6. PubMed ID: 1433373
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic significance of thrombocytosis in renal cell carcinoma patients.
    Inoue K; Kohashikawa K; Suzuki S; Shimada M; Yoshida H
    Int J Urol; 2004 Jun; 11(6):364-7. PubMed ID: 15157203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor Prognosis Associated with High Levels of Thymidine Phosphorylase and Thrombocytosis in Patients with Renal Cell Carcinoma.
    Huang X; Wang L; Chen Y; Zheng X; Wang X
    Urol Int; 2017; 98(2):162-168. PubMed ID: 27532673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 in renal cell carcinoma.
    Tsukamoto T; Kumamoto Y; Miyao N; Masumori N; Takahashi A; Yanase M
    J Urol; 1992 Dec; 148(6):1778-81; discussion 1781-2. PubMed ID: 1433606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinoma.
    Dawson NA; Barr CF; Alving BM
    Am J Med; 1985 Apr; 78(4):682-6. PubMed ID: 3985042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma with skull base metastasis preceded by paraneoplastic signs in a chronic hemodialysis patient.
    Endo K; Okano R; Kuroda Y; Yamada S; Tabei K
    Intern Med; 2001 Sep; 40(9):924-30. PubMed ID: 11579958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis.
    Chuang YC; Lin AT; Chen KK; Chang YH; Chen MT; Chang LS
    J Urol; 1997 Nov; 158(5):1684-7. PubMed ID: 9334578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.